Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,085 across all filing types
Latest filing 2017-01-09 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
2017年第一次临时股东大会的决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2017 first extraordinary general meeting (临时股东大会) of the company 西藏易明西雅医药科技股份有限公司. It includes information about the meeting notice, time, location, attendance, voting results on specific proposals, and legal opinions confirming the validity of the meeting and voting process. The document does not contain financial statements or management discussion of financial results, nor is it a presentation or a report publication announcement. It is a formal announcement of the voting results from a shareholders' meeting, which fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 2534 characters, which is consistent with a detailed voting results announcement rather than a full report or presentation.
2017-01-09 Chinese
2017年第一次临时股东大会的法律意见书
Legal Proceedings Report Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the legality and procedures of a company's 2017 first extraordinary general meeting (临时股东大会). It details the convening, attendance, voting procedures, and results of the shareholders' meeting. The document does not contain financial statements or results but focuses on the validation and legality of the shareholder meeting and its resolutions. This type of document is a legal proceedings report related to corporate governance and shareholder meetings, not an announcement of voting results or a proxy solicitation. Therefore, it fits best under the category of Legal Proceedings Report (LTR). The document length is 2878 characters, which is not extremely short, and it contains substantive legal opinion content rather than just an announcement or certification. Hence, the classification is LTR with high confidence.
2017-01-09 Chinese
公司章程（2017年1月）
Governance Information Classification · 100% confidence The document is titled "西藏易明西雅医药科技股份有限公司 章程" which translates to "Articles of Association" or "Company Bylaws" of Tibet Aim Pharm. Inc. It contains detailed chapters on company organization, shareholder rights, board of directors, management, financial accounting, profit distribution, auditing, and procedures for shareholder meetings. The content is legal and governance-related, focusing on the internal rules, structure, and governance practices of the company. There is no indication of financial statements, audit opinions, earnings data, or meeting results. The document is lengthy (15,000 characters) and is a full text of the company’s articles of association, not an announcement or summary. Therefore, it fits the category of Governance Information (CGR).
2017-01-09 Chinese
关于召开2017年第一次临时股东大会提示性公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed announcement about the convening of the 2017 first extraordinary general meeting (临时股东大会) of the company 西藏易明西雅医药科技股份有限公司. It includes information about the meeting date, voting methods (on-site and online), agenda items to be discussed and voted on, registration procedures, and proxy voting instructions. There is no financial data or report content, but rather a notice and instructions related to the shareholders' meeting. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings. The document is not a report itself, nor a voting result announcement, but a preparatory notice for the meeting and voting process.
2017-01-02 Chinese
关于2017年第一次临时股东大会更正公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a correction announcement related to the classification of a voting matter at the 2017 first extraordinary general meeting (临时股东大会) of the company. It clarifies that a particular agenda item should be treated as a special voting matter rather than an ordinary one. The document does not contain financial statements, management discussion, or detailed report content. It is an announcement correcting information about a shareholder meeting and voting procedures. Therefore, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it pertains to shareholder voting matters and corrections to voting classifications.
2016-12-29 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by a company listed on the Shenzhen Stock Exchange regarding abnormal stock trading fluctuations. It explains the situation, confirms no undisclosed material information, discusses risks related to business operations, cooperation, product quality, tax and government subsidies, and regulatory policies affecting the company. The document is titled as a "股票交易异常波动公告" (Stock Trading Abnormal Fluctuation Announcement) and does not contain financial statements or detailed financial results. It is a regulatory disclosure related to stock price and trading activity, not a financial report, earnings release, or management discussion. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2016-12-29 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.